Loading...
Loading...
EW| Name | Value |
|---|---|
| Revenues | 1,530.2M |
| Cost of Revenue | 343.0M |
| Gross Profit | 1,187.2M |
| Operating Expense | 739.0M |
| Operating I/L | 327.2M |
| Other Income/Expense | 11.3M |
| Interest Income | 9.1M |
| Pretax | 338.5M |
| Income Tax Expense | 33.0M |
| Net Income/Loss | 307.1M |
Edwards Lifesciences Corporation specializes in providing products and technologies for structural heart disease, critical care, and surgical monitoring globally. The company's key offerings include transcatheter heart valve replacement and repair products for minimally invasive heart valve procedures, as well as surgical structural heart solutions such as aortic surgical valves and tissue valved conduits. Additionally, Edwards Lifesciences offers critical care solutions, including advanced hemodynamic monitoring systems and hypotension prediction software for surgical and intensive care settings. The company generates revenue through direct sales and independent distributors.
